For example, in chronic HF patients in the RED-HF (Reduction of Events by Darbepoetin Alfa in Heart Failure) trial, among a range of cardiac biomarkers only hsTnT added to NT-proBNP in the prediction of adverse outcome.26 Here, NPPB is linked to heart failure.